Literature DB >> 11199310

Altruism and the volunteer: psychological benefits from participating as a research subject.

B J Seelig1, W H Dobelle.   

Abstract

Psychiatric assessment of potential volunteers for hazardous biomedical experimentation should include an assessment of the motivations underlying the altruistic action of volunteering. Screening goals include evaluation of informed consent as well as screening out experimental subjects who would be likely to be psychologically harmed by participation. This discussion of psychological issues to be considered, beyond those of informed consent and screening for severe psychopathology, originated in the psychiatric screening of the small group of original volunteers for the "Dobelle eye" Artificial Vision Project. These individuals entered the project over 20 years ago at a time when they could expect no tangible benefit from participation. Superficially altruistic behavior, such as volunteering for this project, serves multiple psychological functions and in a given clinical case, the determinants are often complex. A spectrum of altruistic behavior is suggested, based on interviews with these original subjects as well as from extensive evaluation of patients studied in the setting of psychoanalytic treatment with one of the authors (B.J.S.). We suggest that adaptive altruism can explain the finding that some volunteers gained actual psychological benefit from their participation. This unanticipated finding, that participating in research as an experimental subject can result in lasting improvement in self-esteem, is discussed. Suggestions are made for increasing the likelihood of such benefit. Ethical ramifications are addressed.

Entities:  

Mesh:

Year:  2001        PMID: 11199310     DOI: 10.1097/00002480-200101000-00002

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  6 in total

1.  Declining altruism in medicine.

Authors:  Roger Jones
Journal:  BMJ       Date:  2002-03-16

2.  Altruism and peer-led HIV prevention targeting heroin and cocaine users.

Authors:  Mark R Convey; Julia Dickson-Gomez; Margaret R Weeks; Jianghong Li
Journal:  Qual Health Res       Date:  2010-07-16

3.  Harmonization of Outcomes and Vision Endpoints in Vision Restoration Trials: Recommendations from the International HOVER Taskforce.

Authors:  Lauren N Ayton; Joseph F Rizzo; Ian L Bailey; August Colenbrander; Gislin Dagnelie; Duane R Geruschat; Philip C Hessburg; Chris D McCarthy; Matthew A Petoe; Gary S Rubin; Philip R Troyk
Journal:  Transl Vis Sci Technol       Date:  2020-07-16       Impact factor: 3.283

4.  A guided self-help intervention targeting psychological distress among head and neck cancer and lung cancer patients: motivation to start, experiences and perceived outcomes.

Authors:  Anne-Marie H Krebber; Cornelia F van Uden-Kraan; Heleen C Melissant; Pim Cuijpers; Annemieke van Straten; Annemarie Becker-Commissaris; C René Leemans; Irma M Verdonck-de Leeuw
Journal:  Support Care Cancer       Date:  2016-09-01       Impact factor: 3.603

5.  The role of functional, social, and mobility dynamics in facilitating older African Americans participation in clinical research.

Authors:  Eve T Shapiro; Jay T Schamel; Kimberly A Parker; Laura A Randall; Paula M Frew
Journal:  Open Access J Clin Trials       Date:  2017-04-07

6.  Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment.

Authors:  Gail E Henderson; Holly L Peay; Eugene Kroon; Rosemary Jean Cadigan; Karen Meagher; Thidarat Jupimai; Adam Gilbertson; Jill Fisher; Nuchanart Q Ormsby; Nitiya Chomchey; Nittaya Phanuphak; Jintanat Ananworanich; Stuart Rennie
Journal:  J Med Ethics       Date:  2017-11-10       Impact factor: 2.903

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.